Russkamp, Norman F <br/><br/>
Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  Sep 2015 
 - 3762-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.15-271635  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Lung Injury--drug therapy<br/>Animals<br/>CCR5 Receptor Antagonists--pharmacology<br/>Complement Activation<br/>Complement C3a--genetics<br/>Complement C5a, des-Arginine--genetics<br/>Cyclohexanes--pharmacology<br/>Leukocytes--metabolism<br/>MAP Kinase Kinase 1--genetics<br/>MAP Kinase Kinase 2--genetics<br/>Maraviroc<br/>Mice<br/>Mice, Knockout<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Pulmonary Alveoli--metabolism<br/>Receptor, Anaphylatoxin C5a--genetics<br/>Receptors, CCR5--genetics<br/>Triazoles--pharmacology